ReviewBMC pharmacology & toxicology2026

Drug re-purposing to improve outcomes in the management of prostate cancer - aims, outcome measures and design of current phase III trials.

Duncan C Gilbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.